Image via Pulse2 — funding news
Last updated
Bristol Myers Squibb: Product Launch
Bristol Myers Squibb launched Relopduo, a fixed-dose combination dermatology-cancer drug, in India. The drug received USFDA approval in 2022 and is now being commercialized in the Indian market.
Source: Pulse2 — funding news
The leadership read
A product move like this reshapes Bristol Myers Squibb's org chart as much as its roadmap. Scaling in Biotech & Pharma rests on product leadership that can carry a launch to adoption and commercial hires who turn early traction into pipeline. The Asia tell is whether senior GTM appointments follow; unsupported launches stall.
Market context: The wider read — a Talent Market Index of 100.4 (Neutral), down 1.1 month-on-month — shows Asia signal flow steady (-1.3pts).
Bristol Myers Squibb: 6 signals in the last 90 days — above the Biotech & Pharma median of 1 across 25 tracked companies; 0.4% of MitchelLake's Asia signal flow; 8 tracked across 93 days.
MitchelLake in this thematic
Also at Bristol Myers Squibb →
More signals across Biotech & Pharma
Product Launch · Asia
Biogen →Biogen's monoclonal antibody felzartamab received first global approval in China for second-line multiple myeloma treatment, in combination with lenalidomide and dexamethasone.
Product Launch · Asia
Celltrion →Celltrion achieved record quarterly earnings (1.4 trillion won / $950M in sales, 451.8B won operating profit) driven by growing sales of newer biosimilar portfolio and improved manufacturing efficiency. YoY sales growth of 45% and operating profit growth of 86.3%.
Partnership · Asia
Bora Pharmaceuticals →Bora Pharmaceuticals signed partnership with Insilico Medicine for AI drug discovery. Company launched group-wide AI in Manufacturing program (BORA AIM) to improve process efficiency across sites.
Ma Activity · Asia
Torrent Pharmaceuticals →NCLT (National Company Law Tribunal) approved Torrent Pharma acquisition of JB Chemicals; merger scheme to take effect after Registrar of Companies filing
Restructuring · Asia
Samsung Biologics →Samsung Biologics unionized workers voted to leave the Samsung Group United Union and form an independent labor union, following months of work-to-rule campaigns and strikes over pay and working conditions.
Geographic Expansion · Asia
Thermo Fisher Scientific →Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Where this lands in our work
- Enterprise Innovation & Transformation →
A launch is the output of a product and engineering leadership layer built before it.
- Executive Search — Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record